Recurring septic shock in a patient with blunt abdominal and pelvic trauma: how mandatory is source control surgery?: a case report by Antonella Frattari et al.
CASE REPORT Open Access
Recurring septic shock in a patient with
blunt abdominal and pelvic trauma: how
mandatory is source control surgery?: a
case report
Antonella Frattari1*, Giustino Parruti2, Rocco Erasmo3, Luigi Guerra3, Ennio Polilli2, Rosamaria Zocaro1,
Giuliano Iervese1, Paolo Fazii4 and Tullio Spina1
Abstract
Background: In critically ill patients with colonization/infection of multidrug-resistant organisms, source control
surgery is one of the major determinants of clinical success. In more complex cases, the use of different tools for
sepsis management may allow survival until complete source control.
Case presentation: A 42-year-old white man presented with traumatic hemorrhagic shock. Unstable pelvic fractures
led to emergency stabilization surgery. Fever ensued with diarrhea, followed by septic shock. Two weeks later, an
abdominal computed tomography scan revealed suprapubic and ischiatic abscesses at surgical sites, as well as
dilated bowel. Debridement of both surgical sites, performed with vacuum-assisted closure therapy, yielded
isolates of carbapenem and colistin-resistant Klebsiella pneumoniae. Antibiotic treatment was de-escalated after 21 days; 4
days later fever, leukocytosis, hypotension and acute renal failure relapsed. Blood purification techniques were started, for
the removal of endotoxin and inflammatory mediators, with sequential hemodialysis. Clinical improvement ensued; blood
cultures yielded Candida albicans and multidrug-resistant Acinetobacter baumannii; panresistant carbapenemase-producing
Klebsiella pneumoniae grew from wound swabs. In spite of shock reversal, our patient remained febrile, with diarrhea.
Control blood cultures yielded Candida albicans, Acinetobacter baumannii and carbapenem-resistant Klebsiella
pneumoniae. His abdominal pain increased, paralleled by a right flank palpable mass. Colonoscopy revealed patchy
serpiginous ulcers. At exploratory laparotomy, an inflammatory post-traumatic pseudotumor of his right colon
was removed. Blood cultures turned negative after surgery. Septic shock, however, relapsed 4 days later. A
blood purification cycle was repeated and combination antimicrobial therapy continued. Surgical wounds and
blood cultures were persistently positive for carbapenem-resistant Klebsiella pneumoniae. Removal of pelvic
synthesis media was therefore anticipated. Three weeks later, clinical, microbiological, and biochemical
evidence of infection resolved.
Conclusions: High quality intensive assistance for sepsis episodes needs a clear plan of cure, aimed to
complete infection source control, in a complex multidisciplinary interplay of specialists and intensive care
physicians.
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Background
Sepsis is a well-recognized factor contributing to poor
outcome after severe traumatic injury [1]. Independent
risk factors for post-traumatic sepsis are massive transfu-
sion of packed red blood cells, high Injury Severity Score
(ISS), surgery, and prolonged intensive care unit (ICU)/
hospital stay [2]. Sepsis is often complicated in its course
in such patients, mainly because of the persistence of
predisposing factors and multidrug-resistant (MDR) bac-
teria involvement, in particular carbapenem-resistant
Klebsiella pneumoniae (CRKP) and other difficult-to-
treat Gram-negative microorganisms [3–5]. To manage
sepsis and septic shock in this setting, complex strategies
and interventional bundles have been deployed in recent
years [6]. These include combination antimicrobial therapy,
infection source control, and other intensive supportive
therapies, whose role is well established; blood purification
techniques may play an additional role [6–11]. In this sce-
nario, it is useful to describe even single complicated cases,
such as the one reported here, to outline and pinpoint the
role of each of these tools in the global management of pa-
tients with sepsis.
Case presentation
A 42-year-old white man without pre-existing comorbid-
ities was transferred to our unit on 8 September 2014.
He was involved in a car crash on 30 August 2014 with
traumatic hemorrhagic shock and an ISS of 28. Shock
resuscitation according to Advanced Trauma Life Support
(ATLS) guidelines and massive transfusion policy were
immediately started [12]. Upon hemodynamic stabilization,
a total body computed tomography (CT) scan confirmed
unstable pelvic fractures and right flank mesenteric bleed-
ing, without clear evidence of intestinal perforation. Dam-
age control surgery of his pelvic fractures was performed
by positioning external fixators [13, 14]. Transfer to our
unit was then planned for definitive osteosynthesis.
On arrival he had fever and profuse diarrhea, leukocytosis,
normal procalcitonin (PCT), elevated C-reactive pro-
tein (CRP), lactate 0.9 mmol/L, an Acute Physiology
and Chronic Health Evaluation (APACHE) II score of
11, and a Sequential Organ Failure Assessment (SOFA)
score of 3; his Predisposition, Infection, Response, and
Organ Dysfunction (PIRO) score was 5 [15]. He wore a
tracheostomy and was mechanically ventilated on
analgosedation; he was left on parenteral nutrition and
a minimal enteral feeding was started.
Chest X-rays detected a right basal infiltrate. Orthopedic
surgery was postponed. After thorough microbiological
sampling, immune chromatography for Clostridium difficile
was negative, rectal swabs grew MDR Acinetobacter bau-
mannii, whereas blood cultures yielded coagulase-negative
staphylococci. His antibiotic therapy was modified as
described here and in Table 1. As external fixators poured
purulent secretions, on day 15 he underwent definitive pel-
vic osteosynthesis in spite of persistent fever and diarrhea
(Fig. 1). Septic shock ensued 24 hours after surgery, with
oliguria, leukocytosis, PCT 4.39 ng/ml, CRP 46.6 mg/L,
and lactate 1.17 mmol/L; his SOFA score rose to 6. After
adequate fluid resuscitation, norepinephrine was added for
persistent hypotension, based on data of hemodynamic
monitoring (cardiac output and stroke volume variation
using PiCCO Plus monitoring system) and trends of central
venous saturation of oxygen (ScVO2). Low doses of steroids
were prescribed for the first 3 days. Microbiological sam-
pling included blood cultures, quantitative culture of tra-
cheal secretions, and culture of urine [6]. Blood cultures
were negative; urine and tracheal aspirate samples were
positive for CRKP and MDR A. baumannii.
He had a short-lasting improvement, with fever,
abdominal pain, and vomiting relapsing after a few days;
a repeated CT scan of his abdomen revealed suprapubic
and left ischiatic abscesses at surgical sites, as well as di-
lated bowel due to paralytic ileus. Surgical debridement
was performed, followed by vacuum-assisted closure
(VAC) therapy [16]. Intraoperative microbiological sam-
pling revealed multiple CRKP isolates, with a worsened
resistance profile, including colimycin (colistin) resist-
ance. He improved and a control radiographic (RX) scan
of his thorax was negative; bronchoalveolar lavage (BAL)
sampling, however, confirmed persistence at low bacter-
ial load of CRKP. After 21 days, colimycin was with-
drawn. However, 4 days later, he had fever and severe
leukocytosis; he relapsed with acute renal failure: cre-
atinine 2.53 mg/dL and acute kidney injury (AKI) stage
2 according to the Kidney Disease: Improving Global
Outcomes classification (KDIGO) [17]. His PCT levels
rose above 100 ng/ml, his lactate was 3.3 mmol/L, and
his SOFA score was 10. After further blood sampling for
blood cultures and multiplex polymerase chain reaction
(PCR; Magicplex™ Sepsis Test, Seegene), colimycin and ani-
dulafungin were restarted with the addition of rifampicin
(Table 1). Multiplex PCR revealed A. baumannii and Can-
dida albicans. To support septic shock recovery, two extra-
corporeal hemoperfusion devices were used: the Polymyxin
B-Immobilized Cartridge (Toraymyxin® PMX 20-R, Toray
Medical, Tokyo, Japan), allowing endotoxin removal and
coupled plasma filtration adsorption (CPFA; CPFA®
LYNDA®, Bellco, Mirandola, Italy), a hydrophobic resin
with high affinity for many inflammatory mediators. Within
3 days, two Polymyxin B and three CPFA treatments were
overall delivered. Clinical improvement ensued; his PCT fell
to 19.25 ng/ml and serum creatinine to 1.82 mg/dL. Micro-
biological samples yielded: MDR A. baumannii and CRKP
from tracheal aspirate, C. albicans and MDR A. baumannii
from blood cultures, and A. baumannii and panresistant
CRKP from wound swabs. In spite of septic shock reversal,
he remained febrile with diarrhea and worsening anemia in
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the next 2 weeks. Control blood cultures (three lots) were
persistently positive for C. Albicans, A. baumannii and
CRKP. Ophthalmoscopy revealed retinal involvement, so
that sequential therapy with liposomal amphotericin B was
started. In the following weeks frequent vomiting ensued,
impeding any enteral nutrition; his abdominal pain in-
creased, paralleled by a palpable mass in his right flank.
Colonoscopy revealed patchy serpiginous ulcers; a repeated
CT of his abdomen revealed a periappendicular mass.
Based on such data, after repeated multidisciplinary con-
sults, an exploratory laparotomy was at last performed and
an inflammatory pseudotumor of his right colon was diag-
nosed and resected with ileostomy. Soon after surgery, his
blood cultures turned negative. Colimycin was interrupted.
Once more, septic shock relapsed 4 days later.
Leukocytosis, hypotension, PCT >100 ng/mL, renal failure,
and lactate 4.0 mmol/L led to a SOFA score of 11; creatin-
ine zenith was 4.73 mg/dL. Combination antibiotic therapy
was modified (see Table 1) and a single Polymyxin B extra-
corporeal hemoperfusion cycle was repeated. Blood cul-
tures were persistently positive for CRKP. After
interdisciplinary consultation, removal of pelvic synthesis
media was anticipated. Shortly after surgery, he improved;
3 weeks later, microbiological and biochemical evidence of
infection resolved, as well as gastric atonia. Combination
therapy was continued for 56 days (Table 1). He was trans-
ferred to the orthopedic ward after 146 days of ICU stay
and later to rehabilitation. At present, he is doing well at
home able to walk.
Discussion
Our patient had a severe abdominal and pelvic trauma
which received immediate intensive transfusional and sur-
gical support [12, 14]. His long-lasting watery diarrhea
was probably trauma related: his first CT scan revealed
signs of post-traumatic right colon injury, which probably
caused altered intestinal motility, ulcerative colitis, and
ultimately cecal inflammatory pseudotumor [18–20]. Due
to trauma, he developed two bloodstream seeding sites –
the intestine and pelvic surgical sites – which we could
not eliminate until late in his clinical course; this influ-
enced the heavy and inevitable selection of MDR bacteria
[4, 21]. So we needed to treat his relapsing septic episodes
to enable his survival throughout the time needed for
appropriate and definitive infection source control. He did
in fact survive a series of five septic shock episodes with-
out residual signs of kidney or other organ failure at
discharge. We used a complex, costly, and articulated
strategy to achieve this aim, which we find totally justified
in this case and worth adequate consideration [22, 23].
In this strategy, early deployment of blood purification
techniques to not only support renal function during the
acute phases of renal overload, but also to remove endo-
toxins and cytokines, had a key role. Alongside extracor-
poreal therapies for the treatment of renal failure, new
extracorporeal depurative techniques have been developed
for the removal of endotoxin and inflammatory mediators
[24]. Toraymyxin® is the reference for the treatment of
patients with endotoxic septic shock unresponsive to
conventional therapies, with a high endotoxin removal
capacity per hemoperfusion treatment. Toraymyxin® was
designed to adsorb endotoxin, but it probably adds other
mechanisms of immunomodulation as direct adsorp-
tion of some inflammatory mediators (Fig. 2a) [25].
Another technique, named CPFA, has been proposed to
non-specifically remove both proinflammatory and anti-
inflammatory mediators [26]. This technique consists of a
combination of filters and a resin cartridge to remove a
number of different cytokines including tumor necrosis
factor-α, interleukin (IL)-6 and IL-10, while simultaneously
providing continuous renal replacement therapy (CRRT)
for renal/fluid support (Fig. 2b). Application of CPFA has
been demonstrated to reduce hospital mortality in patients
with septic shock in ICUs [27]. The Compact 2 study, an
ongoing multicentric trial, may shed further light on this
point [24]. In the case of our patient, with relapsing
episodes of septic shock in the absence of timely infectious
source control, we decided to sequentially use both extra-
corporeal depurative techniques in the search of optimal
control of both mechanisms of shock pathogenesis: that is,
endotoxin release from persisting infectious foci, and cyto-
kine production due to host response.
It is important to underline the relevant role that interdis-
ciplinary discussion had in this patient. In particular, micro-
biological evidence of persistent bacterial and fungal
translocation suggested a laparoscopic evaluation, which
surgeons had first denied on the basis of CT and clinical
evidence. Similarly, the interplay with orthopedic surgeons
led to the choice of the first reasonable slot for synthesis
media removal. Efforts to use the best of antimicrobial
Fig. 1 Pelvic fracture of the patient after the intervention
of osteosynthesis
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combination therapy for sepsis control [7, 28] were the
fruit of interplay with infectologists. CRKP has become
a major hospital pathogen worldwide, and infections
due to this organism have been associated with high
mortality, especially in cases like ours that harbor panresis-
tant strains [29]. In our case, it is of note that, in the wait
for new antimicrobial options, the combination of two car-
bapenems proved partially effective on panresistant strains
[28, 29].
The room and theatre of all these advanced procedures
was the ICU. This was relevant for our patient, and should
prompt internists to evaluate once more the role of inten-
sive care in the management of patients with sepsis.
Conclusions
High quality intensive assistance for complex cases
involving patients with sepsis may ensue through the
active interplay of ICU physicians and multiple spe-
cialists to define a rational sequence of interventions
aimed to prevent multiple organ failure until control
of the infection source is complete.
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